Course overview
Cognitive Decline and Brain Health
In this course, you will explore the current standard of care in Alzheimer's disease and the standard of care clinicians should strive to achieve with patients. Specific goals for treatment and strategies used to reverse and sustain cognitive decline are addressed.
Faculty
Dale Bredesen, MD
Conference Series
AIHM 2020 Annual Conference
Required Lessons
1
Time to Complete
1 hour
CME Eligible*
.75 Credits
What you will learn
-
Course Summary
-
By the end of this course, learners will be able to:
- Differentiate the current standard of care versus the 21st century standards of care for neurodegenerative diseases.
- Describe strategies used to reverse and sustain cognitive decline in people with Alzheimer's disease.
- Identify goals for treatment and prevention of Alzheimer's disease.
- Recognize the specific reasons for failure of Alzheimer's patients to improve.

Course includes:
Included in this course
Course Faculty
Dale Bredesen, MD
About Dale
Dr. Bredesen earned his MD from Duke University Medical Center and served as Chief Resident in Neurology at the University of California, San Francisco (UCSF), before joining Nobel laureate Stanley Prusiner’s laboratory at UCSF as an NIH Postdoctoral Fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen also directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as founding President and CEO.
Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results. Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times‘ Best-Seller, The End of Alzheimer’s.
Dr. Bredesen’s research explores previously uncharted territory in explaining the physical mechanism behind the erosion of memory seen in Alzheimer’s disease, and has opened the door to new approaches to treatment. This work has led to the identification of several new therapeutic processes that are showing remarkable early results. Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times‘ Best-Seller, The End of Alzheimer’s.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, Irvine School of Medicine and the Academy of Integrative Health & Medicine. The University of California, Irvine School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and cultural and linguistic competency, please visit the CME website.
This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and cultural and linguistic competency, please visit the CME website.
*CME/CEU Credits
The University of California, Irvine School of Medicine designates this enduring materials for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other healthcare professionals completing this activity will be issued a certificate of participation. To successfully earn credit, participants must review the content, complete a quiz with a score of 75% or higher, and submit an evaluation. This course is CME-eligible ending on May 31, 2023. After this date, you will continue to have access to your purchased content, however you will no longer be able to claim CME credits for your participation in the course.
All other healthcare professionals completing this activity will be issued a certificate of participation. To successfully earn credit, participants must review the content, complete a quiz with a score of 75% or higher, and submit an evaluation. This course is CME-eligible ending on May 31, 2023. After this date, you will continue to have access to your purchased content, however you will no longer be able to claim CME credits for your participation in the course.